GRAY MARY ANN

CIK 000126197414 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001261974

Recent Transactions

50 trades

Award
Compass Therapeutics, Inc.$CMPX
Stock Option (Right to Buy)
2026-01-02+90,000→ 90,000 total
Award
BioAtla, Inc.$BCAB
Common Stock
2025-06-18+23,500→ 77,397 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2025-06-04+10,500→ 10,500 total
Award
Keros Therapeutics, Inc.$KROS
Common Stock
2025-06-04+5,250→ 5,250 total
Award
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2025-05-29+257,832→ 257,832 total
Award
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2025-03-31$1.06/sh+61,202→ 61,202 total
Award
Compass Therapeutics, Inc.$CMPX
Stock Option (Right to Buy)
2025-02-11+40,000→ 40,000 total
Award
BioAtla, Inc.$BCAB
Common Stock
2024-06-13+16,500→ 53,897 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2024-05-30+10,000→ 10,000 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2024-05-22+36,490→ 36,490 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2024-03-28$7.58/sh+8,574→ 8,574 total
Award
Compass Therapeutics, Inc.$CMPX
Stock Option (Right to Buy)
2024-02-09+40,000→ 40,000 total
Award
BioAtla, Inc.$BCAB
Common Stock
2023-12-31+5,995→ 37,397 total
Award
PALISADE BIO, INC.$PALI
Common Stock Options
2023-11-21+6,880→ 6,880 total
Award
PALISADE BIO, INC.$PALI
Restricted Stock Units
2023-11-21+5,820→ 5,820 total
Award
BioAtla, Inc.$BCAB
Common Stock
2023-09-30+8,676→ 31,402 total
Award
BioAtla, Inc.$BCAB
Common Stock
2023-06-30+4,916→ 22,726 total
Award
BioAtla, Inc.$BCAB
Stock Option (Right to Buy)
2023-06-14+50,000→ 50,000 total
Award
PALISADE BIO, INC.$PALI
Common Stock Options
2023-06-11+12,160→ 12,160 total
Award
PALISADE BIO, INC.$PALI
Restricted Stock Units
2023-06-11+5,100→ 5,100 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2023-06-06+10,000→ 10,000 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2023-05-24+12,940→ 12,940 total
Award
BioAtla, Inc.$BCAB
Common Stock
2023-03-31+5,503→ 17,810 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2023-03-31$14.52/sh+4,477→ 4,477 total
Award
Compass Therapeutics, Inc.$CMPX
Stock Option (Right to Buy)
2023-02-08+40,000→ 40,000 total
Award
BioAtla, Inc.$BCAB
Stock Option (right to buy)
2022-06-16+20,000→ 20,000 total
Award
Keros Therapeutics, Inc.$KROS
Stock Options (right to buy)
2022-06-01+8,293→ 8,293 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2022-05-25+8,500→ 8,500 total
Award
Compass Therapeutics, Inc.$CMPX
Stock Option (Right to Buy)
2022-04-26+45,000→ 45,000 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2022-03-31$16.80/sh+3,868→ 3,868 total
Award
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2022-03-07+2,953→ 12,356 total
Award
Sarepta Therapeutics, Inc.$SRPT
Stock Option (right to buy)
2022-03-07+5,077→ 5,077 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2021-12-10+967→ 9,403 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Restricted Stock Units
2021-12-10−967→ 0 total
Award
PALISADE BIO, INC.$PALI
Stock Option (right to buy)
2021-11-18+48,340→ 48,340 total
Award
BioAtla, Inc.$BCAB
Stock Option (right to buy)
2021-06-15+12,307→ 12,307 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2021-06-01+8,293→ 8,293 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2021-05-28+7,500→ 7,500 total
Award
PALISADE BIO, INC.$PALI
Restricted Stock Units
2021-04-01+6,000→ 6,000 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2021-03-31$15.70/sh+3,822→ 3,822 total
Award
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2021-03-03+2,726→ 8,436 total
Award
Sarepta Therapeutics, Inc.$SRPT
Stock Option (right to buy)
2021-03-03+5,518→ 5,518 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2020-12-17+16,587→ 16,587 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Restricted Stock Units
2020-12-10−967→ 967 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-12-10+967→ 5,710 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2020-06-18+7,500→ 7,500 total
Award
PALISADE BIO, INC.$PALI
Restricted Stock Units
2020-04-03+6,000→ 6,000 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2020-03-31$15.06/sh+3,984→ 3,984 total
Award
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-02-28+2,075→ 4,743 total
Award
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2020-02-28+3,685→ 3,685 total

Companies

Recent Filings

Address

C/O DYAX CORP. 300 TECHNOLOGY SQUARE

CAMBRIDGE, MA, 02139

View on SEC.gov